Federal health authorities have asked the manufacturers of four widely used immunosuppressive drugs to bolster safety warnings on the risk of developing opportunistic fungal infections.
The drugs, Humira, Cimzia, Enbrel and Remicade, belong to a class of medications known as tumor necrosis factor alpha blockers (TNF-alpha blockers), which suppress the immune system and are approved to treat several conditions including rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, plaque psoriasis, ankylosing spondylitis and Crohn's disease.
Ashley and Kyle were newlyweds in early 2022 and thrilled to be expecting their first child....
More than two years after most abortions became illegal in Alabama, the West Alabama Women’s Center...
A Massachusetts town has ordered its parks to close from dusk to dawn due to a...
